Dialysis world news


Acute kidney injury assessment and treatment - EMS1.com

A 36-year-old female presents in moderate respiratory distress, following a night of sleeplessness, nausea, vomiting and diarrhea. Speaking in short sentences, she denies chest pain, but is experiencing abdominal discomfort. She is hypertensive and tachycardic. Upon physical exam you note diminished lung sounds in the bases of both lungs. Her abdomen is soft and tender to the touch. You also notice signs of edema in her ankles, which the patient describes as a new onset, about one to two days ago. She has just started chemotherapy for ovarian cancer and was given an intraperitoneal injection of carboplatin.

<![CDATA[ .related-content-container a{font-size: 11px;} ]]>

What might be causing these signs and symptoms?

For most EMS providers, renal failure would not be the first medical condition that would come to mind. However, this patient is experiencing an acute, potentially life-threatening kidney injury that is the result of acute poisoning associated with the potent anti-cancer medication she had just received. Let's take a look at renal complications that are less commonly seen, but can present to prehospital providers.

Kidney injury: How big is the problem?

The rate of diagnosed kidney injuries (KI), formerly known as renal failure, is on the rise. While experts debate whether better, more consistent definitions of KI is contributing to the dramatic increase, there seems to be consensus that overall the percentage of people in the United States with KI has increased.[1] 

Acute kidney injuries, or acute renal failure (ARF), is also increasing among patients who are hospitalized for non-renal specific conditions.[3] It can worsen the ability of these patients to recover from their original medical problem or condition.

Kidney anatomy and pathophysiology: A quick overview

There are two kidneys in the human body; each is roughly the size of a clenched fist. They are located in the retroperitoneal space, behind the much larger abdominal cavity. One of the kidney's main functions is to filter waste by-products and toxins from the blood as it passes through the kidney.

The filtration process is complex, and changes according to the demands of the body. The primary functional unit of the kidney is called a nephron; on average, there are an estimated 1 million nephrons within each kidney. Blood enters the first part of the nephron called the glomerulus. Much of the blood's liquid plasma is forced out of the glomerulus and into the surrounding space called the Bowman's capsule, carrying with it waste and toxins, along with nutrients and necessary electrolytes like potassium.

The fluid is collected in the second part of the nephron known as the renal tubules. The tubules selectively reabsorb water, nutrients and electrolytes back into the capillaries carrying the blood cells. As the process continues, the plasma containing mostly waste is concentrated in the renal tubule.

Toward the end of this process, the nephron will secrete any last toxins or excess substances out of the capillaries and into the final part of the renal tubule, such as medications. The now highly concentrated plasma is eventually dumped into collecting ducts, forming urine that is drained from each kidney via its ureter into the urinary bladder.

To summarize, there are three steps to how the nephron clears the bloodstream:

  1. Filtration in the glomerulus
  2. Reabsorption of water and needed materials in the beginning segment of the tubule
  3. Secretion of final waste products at the end of the tubule.

Kidney injury: What is it?

Kidney injuries can be broadly classified into two categories, chronic and acute. An acute kidney injury (AKI) is defined as an sudden decline in renal function that occurs over a few hours to a few days.[4] Patients with AKI rapidly lose their ability to filter blood, resulting in an increasingly toxic blood stream and fluid overload.

Conditions that lead to AKI can be categorized into three areas:

  1. Prerenal causes are mostly related to blood flow to the kidney. Hypotension secondary to decreased cardiac output, blood volume or massive vasodilation is the most common prerenal cause of AKI.
  2. Postrenal problems are usually related to the inability to remove urine from the body, either due to an obstruction somewhere in the excretion apparatus, such as a kidney stone in the ureter, or problems with the bladder retaining urine.
  3. Intrinsic problems happen within the kidney itself. There can be damage to the glomerulus, renal tubules or the tissue containing the nephrons.

Diseases such as lupus erythematosus, streptococcal or viral infections, or increasingly, medications such as antibiotics, nonsteroidal anti-inflammatory drugs (ibuprofen is an example) can cause the kidney to suddenly lose function. The patient in the case study, the 36-year-old female, has an intrinsic problem.

There are several signs and symptoms that are associated with AKI. They include:

  • Sudden changes in mental status or mood
  • Nausea, vomiting and/or diarrhea
  • Rapid onset of numbness or tingling, especially around the hands and feet
  • Sudden onset of edema to the feet and/or hands
  • Rapid onset of hypertension
  • Rapid decrease in urine output
  • Seizures, muscle twitching as a result of increasing potassium levels (hyperkalemia)
  • Changes in the electrocardiogram such as elevated or peaked T waves associated with hyperkalemia

Recall that in AKI these signs and symptoms will occur over just a few hours or days. As fluid rapidly builds up, it will begin to shift to other areas of the body, including the lungs. This will result in shortness of breath. Patients may experience chest pain as a result of fluid overload placing additional workload on the heart.

Compared to AKI, chronic kidney injuries occur much more slowly. Diseases such as hypertension and diabetes are considered risk factors for developing chronic kidney failure.

There may be few signs of failure during the evolution of the disease; the kidneys may be down to 25 percent of normal function by the time symptoms become noticeable.[5] Many patients report a slow, steady onset of fatigue, general weakness, slow onset of pedal edema, and decreasing urine output. Resting blood pressure rises as fluid slowly builds up in the body.

Over time, even with aggressive medical management, end-stage renal disease (ESRD) may develop. At this point the kidney's ability to perform is insufficient to maintain normal blood volume and composition. Patients with ESRD require their blood to be artificially dialyzed, either through hemodialysis or peritoneal dialysis. Certain patients may become eligible for kidney transplants. Efforts are underway to develop artificial kidneys that can be implanted[6] or worn on a belt.[7]

Assessment of kidney injury

An initial impression of an acute kidney injury may be hard to determine at first glance. EMS providers will likely consider more common causes of respiratory distress, chest pain or seizures. Pay close attention to the history of the illness and the timing of the physical findings. The patient, family or caregiver may describe an unusual sign or symptom occurring within the past few days, such as swelling of the feet or hands, or a sudden change in the patient's level of alertness.

Consider possible AKI if there is an introduction of a medication described above. Ask about urinary habits; has there been a decrease in output? Has the color of urine become darker, more concentrated? Especially in the absence of a fever or infection history, these may be signs of renal impairment.

Remember that kidney failure may be the result of another problem that is causing decreased blood flow. Patients with sepsis are at high risk for developing AKI.[8]

Treatment of kidney injury

Out of hospital treatment is mainly supportive. Preserve the patient's airway patency if necessary and ensure adequate ventilation and oxygenation. Monitoring oxygen saturation via pulse oximetry (SpO2) and carbon dioxide levels during exhalation using waveform capnography (ETCO2) will guide the EMS provider in appropriate ventilation rates and volume.

If hypotension exists, volume expansion may be required for both kidney and overall perfusion needs. In severe sepsis, a vasopressor may also be needed for increasing cardiac output.

On the other hand, hypertensive states require careful restriction of fluid delivery. If pulmonary edema exists, consider a diuretic such as furosemide. Nitrate therapy may help reverse fluid shifts by reducing hypertension temporarily through vasodilatation. Continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) can force pulmonary interstitial fluid overload back into the vasculature, increasing gas exchange effectiveness.

There may be other causes for altered mental status that might be present. Remember to check blood glucose levels and treat as necessary.

Encounters with patients experiencing an acute kidney injury may occur rarely for EMS providers, and remain hidden behind other more common causes of medical emergencies. Paying attention to specific signs and symptoms and how quickly they arise might provide a clue to the actual cause of the patient's presentation.

References

1. Slew ED and Davenport A. The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney International (2015) 87, 46–61.

2. Centers for Disease Control and Prevention. National chronic kidney disease fact sheet, 2014. http://www.cdc.gov/diabetes/pubs/pdf/kidney_factsheet.pdf; retrieved 20 April 2015.

3. Waikar SS et al. Diagnosis, Epidemiology and Outcomes of Acute Kidney Injury. Clinical Journal of the American Society of Nephrology. 2008. vol. 3 no. 3844-861.

4. Hughes PS. Classification systems for acute kidney injury. Medscape 16 October 2014. http://emedicine.medscape.com/article/1925597-overview. Retrieved 20 April 2015.

5. Nordqvist C. What is chronic renal failure? Medical News Today. 10 September 2014. http://www.medicalnewstoday.com/articles/172179.php retrieved 21 April 2015.

6. University of California, San Francisco. The Kidney Project. http://pharm.ucsf.edu/kidney. Retrieved 25 April 2015.

7. Barbor M. New Wearable Artificial Kidney Improves Mobility. Medscape Medical News. 9 February 2015. http://www.medscape.com/viewarticle/839462. Retrieved 25 April 2015.

8. Majumbar A. Sepsis-induced kidney injury. Indian Journal of Critical Care Medicine. 2010:  Jan-Mar; 14(1): 14–21.

...

 
Measuring kidney health could predict heart disease risk - NephrologyNews.com

Simple measures of kidney function and damage may be just as good at predicting who is at risk for heart failure and death from heart attack and stroke as traditional tests of cholesterol levels and blood pressure, new Johns Hopkins Bloomberg School of Public Health-led research suggests.

The researchers say their data, published in the  may 29 issue of Lancet Diabetes and Endocrinology, may help physicians make better decisions about whether patients need lifestyle modifications such as better diets and more exercise or treatments such as statins, medication widely used for cardiovascular disease prevention. 

The researchers note, the information is already widely available for many patients. The most common assessment of kidney function, the estimated glomerular filtration rate, or eGFR, is given an estimated 290 million times every year in the United States. Another key test measures albuminuria, and higher amounts indicate the presence of kidney damage. It is also a fairly common test, particularly in patients with diabetes, hypertension and kidney disease.


Related
NKF survey reveals many Americans know little about their kidneys


“If health care providers have data on kidney damage and kidney function —which they often do — they should be using those data to better understand a patient’s risk of cardiovascular disease,” says study lead author Kunihiro Matsushita, MD, PhD, an assistant scientist in the Bloomberg School’s Department of Epidemiology. “Cholesterol levels and blood pressure tests are good indicators of cardiovascular risk, but they are not perfect. This study tells us we could do even better with information that often times we are already collecting.”

The Chronic Kidney Disease Prognosis Consortium coordinated by Professor Josef Coresh, MD, PhD, and colleagues at the Johns Hopkins Bloomberg School of Public Health analyzed data from 24 studies that included more than 637,000 participants with no history of cardiovascular disease and the results of tests of eGFR and albuminuria. They found that both eGFR levels and albuminuria independently improved prediction of cardiovascular disease in general and particularly heart failure and death from heart attack and stroke, but albuminuria was the stronger predictor. It outperformed cholesterol levels and systolic blood pressure – and even whether someone is a smoker—as a risk factor for heart failure and death from heart attack or stroke.

People with chronic kidney disease are twice as likely to develop cardiovascular disease as those with healthy kidneys and roughly half of them die from it before they reach kidney failure.

Several clinical guidelines already recommend that patients with diabetes, hypertension and the possibility of chronic kidney disease be evaluated for kidney function and kidney damage.

Matsushita says the new data demonstrate that other individuals not covered by the recommendations may also benefit from having their kidneys assessed. For example, he says, the ability to predict cardiovascular risk was particularly robust in black study participants when eGFR and albuminuria were considered.

The biological mechanisms linking kidney disease to cardiovascular disease aren’t well understood, but Matsushita says that poorly functioning kidneys can lead to a fluid overload that may result in heart failure. He says that people with kidney disease tend to not receive certain medications that can reduce heart ailments, such as statins, likely because patients with kidney disease frequently are excluded from clinical trials performed to prove the efficacy of these medicines.

“Estimated Glomerular Filtration Rate and Albuminuria for Prediction of Cardiovascular Outcomes: A Collaborative Meta-Analysis” was written by Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Tazeen Jafar, Simerjot K. Jassal, Gijs W. D. Landman, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael Shlipak, Marcello Tonelli, Jonathan Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron Gansevoort, Mark Sarnak, David G. Warnock, Mark Woodward, and Johan Arnlov, for the CKD Prognosis Consortium.

...

 
National Kidney Foundation launches new patient advocacy program - NephrologyNews.com

The National Kidney Foundation has launched a new patient advocacy and engagement program to expand its grassroots network at the state level. The Kidney Action Committee is comprised of 60 patient liaisons, including one from each state, who are personally affected by kidney disease. These individuals will use their experience to advise government agencies, research organizations, and policy and health organizations on kidney disease.

They will also provide input on the development of NKF public policy positions and the implementation of kidney disease education programs.This new program builds upon NKF’s Advocacy Action Center —a group of over 60,000 people who advocate on behalf of kidney patients.


Related:

Become a kidney patient advocate on Capitol Hill


“We’re strengthening our national advocacy presence by expanding our multi-state efforts,” said Kevin Longino interim Executive Officer of the National Kidney Foundation. “These 60 individuals will be the face of NKF at the state level. It’s an important role, but we have very dedicated volunteers who are passionate about making sure the needs of kidney patients are addressed.”


Members of the Kidney Action Committee will promote NKF priorities locally and nationally through media interviews, visits with lawmakers, and special events.

“As someone affected by kidney disease, I know how crucial advocacy and engagement is to furthering our cause,” said Alexandra Harrison, a newly-elected patient liaison. “I’m looking forward to creating local momentum behind the key issues that will make a positive difference for kidney patients in California and across the country.”

...

 
Dialysis Patients More Likely to Die in Winter - Renal and Urology News
May 29, 2015 Dialysis Patients More Likely to Die in Winter - Renal and Urology News
Austrian study finds a death rate in winter of 1.60 deaths per 100 patient-months compared with 1.06 deaths per 100 patient-months in summer.

Mortality among dialysis patients follows a seasonal pattern, with higher death rates during winter months, according to a new Austrian study presented at the European Renal Association-European Dialysis and Transplant Association 52nd congress in London.

The retrospective cohort study, by Claudia Friedl, MD, of the Medical University of Graz, Austria, and colleagues, included 2,438 dialysis patients: 902 women and 1,536 men. Patients had a mean age of 63.9 years. During the study, 1,836 patients died. The researchers reported that all-cause mortality was highest in winter (1.60 deaths per 100 patient-months) and lowest in summer (1.06 deaths per 100 patient-months).

The investigators concluded that physicians should possibly pay more attention to preventive measures like seasons vaccination or intensive control of cardiovascular risk factors, such as high blood pressure), especially in winter.

Friedl's team noted that their study findings are similar to those of a U.S. study. That study, by Len A. Usvyat, PhD, of the Renal Research Institute in New York, and colleagues, included 15,056 dialysis patients from 6 states of varying climates. All-cause mortality was significantly higher in winter compared with other seasons: 14.2 deaths per 100 patient-years in winter compared with 13.1 in spring, 12.3 in autumn, and 11.9 in summer, the authors reported in the Clinical Journal of the American Society of Nephrology (2012;7:108-115).

...

 
Stroke Risk Lower with Kidney Transplants vs. Dialysis - Renal and Urology News
May 29, 2015 Stroke Risk Lower with Kidney Transplants vs. Dialysis - Renal and Urology News
Their risk of a stroke was 46% lower for transplant recipients than that of dialysis patients.

Patients with end-stage renal disease (ESRD)who have had a kidney transplant have nearly half the risk of stroke compared with patients on hemodialysis, Australian researchers reported at the European Renal Association-European Dialysis and Transplant Association 42nd Congress in London.

Philip Masson, MBChB, of the University of Sydney, and colleagues examined stroke risk factors in a retrospective cohort study of 10,745 ESRD patients. The cohort experienced 640 stroke events during 47,472 person-years of follow-up.

Compared with dialysis patients, kidney transplant recipients had a 46% lower risk of stroke. Patients who had a previous stroke had a 2.5 times higher risk of stroke than those who never had a stroke. Stroke risk increased with age: It was 6 times higher in patients aged 50 – 70 years than those aged younger than 30 years. Smoking increased the risk of stroke by 55% compared with never having smoked. Women were 39% more likely than men to suffer a stroke.

Results showed that risk factors for ischemic and hemorrhagic stroke were similar.

...

 
<< Start < Prev 111 112 113 114 115 116 117 118 119 120 Next > End >>

Page 111 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.